Details for New Drug Application (NDA): 212333
✉ Email this page to a colleague
NDA 212333 describes ISOTRETINOIN, which is a drug marketed by Actavis Labs Fl, Amneal Pharms Ny, Aurobindo Pharma, Upsher Smith Labs, and Zydus Pharms, and is included in six NDAs. It is available from seven suppliers. Additional details are available on the ISOTRETINOIN profile page.
The generic ingredient in ISOTRETINOIN is isotretinoin. There are thirteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the isotretinoin profile page.
The generic ingredient in ISOTRETINOIN is isotretinoin. There are thirteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the isotretinoin profile page.
Summary for 212333
| Tradename: | ISOTRETINOIN |
| Applicant: | Upsher Smith Labs |
| Ingredient: | isotretinoin |
| Patents: | 0 |
Suppliers and Packaging for NDA: 212333
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ISOTRETINOIN | isotretinoin | CAPSULE;ORAL | 212333 | ANDA | Upsher-Smith Laboratories, LLC | 0245-0570 | 0245-0570-01 | 3 BLISTER PACK in 1 BOX (0245-0570-01) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0245-0570-89) |
| ISOTRETINOIN | isotretinoin | CAPSULE;ORAL | 212333 | ANDA | Upsher-Smith Laboratories, LLC | 0245-0571 | 0245-0571-01 | 3 BLISTER PACK in 1 BOX (0245-0571-01) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0245-0571-89) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
| Approval Date: | Sep 21, 2021 | TE: | AB2 | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 20MG | ||||
| Approval Date: | Sep 21, 2021 | TE: | AB2 | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 30MG | ||||
| Approval Date: | Sep 21, 2021 | TE: | AB2 | RLD: | No | ||||
Complete Access Available with Subscription
